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Abstract
Background: Radiation-induced bystander responses, where cells respond to their neighbours
being irradiated are being extensively studied. Although evidence shows that bystander responses
can be induced in many types of cells, it is not known whether there is a radiation-induced
bystander effect in breast cancer cells, where the radiosensitivity may be dependent on the role of
the cellular estrogen receptor (ER). This study investigated radiation-induced bystander responses
in estrogen receptor-positive MCF-7 and estrogen receptor-negative MDA-MB-231 breast cancer
cells.
Methods: The influence of estrogen and anti-estrogen treatments on the bystander response was
determined by individually irradiating a fraction of cells within the population with a precise number
of helium-3 using a charged particle microbeam. Damage was scored as chromosomal damage
measured as micronucleus formation.
Results: A bystander response measured as increased yield of micronucleated cells was triggered
in both MCF-7 and MDA-MB-231 cells. The contribution of the bystander response to total cell
damage in MCF-7 cells was higher than that in MDA-MB-231 cells although the radiosensitivity of
MDA-MB-231 was higher than MCF-7. Treatment of cells with 17β-estradiol (E2) increased the
radiosensitivity and the bystander response in MCF-7 cells, and the effect was diminished by anti-
estrogen tamoxifen (TAM). E2 also increased the level of intracellular reactive oxygen species
(ROS) in MCF-7 cells in the absence of radiation. In contrast, E2 and TAM had no influence on the
bystander response and ROS levels in MDA-MB-231 cells. Moreover, the treatment of MCF-7 cells
with antioxidants eliminated both the E2-induced ROS increase and E2-enhanced bystander
response triggered by the microbeam irradiation, which indicates that ROS are involved in the E2-
enhanced bystander micronuclei formation after microbeam irradiation.
Conclusion: The observation of bystander responses in breast tumour cells may offer new
potential targets for radiation-based therapies in the treatment of breast cancer.
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Background
The radiation-induced bystander effect is the appearance
of a biological response in nonirradiated cells neighbour-
ing irradiated cells [1]. The response has been demon-
strated in cultured cells and tissues by using different
irradiation approaches including low fluences of α-parti-
cles [2,3], γ-rays [4,5], heavy ions [6,7], and targeted
microbeams which allow cells to be individually irradi-
ated through either the nucleus or cytoplasm [8-10].
Many endpoints have been reported for the bystander
responses, including DNA damage markers [11,12] cell
death [13], increases in sister chromatid exchanges
[14,15], micronuclei [11,16,17], mutations [18,19]
genomic instability [20,21], malignant transformation
[22,23] and gene expression [24].
Recently, we have found that irradiation through the cyto-
plasm of a cell has a similar probability of triggering a
bystander response to that when the nucleus is directly
irradiated [10,25]. However, the mechanisms underpin-
ning the bystander effect are still unclear, although cell-to-
cell communication [26-28] and several signaling factors
such as cytokines [29], reactive oxygen species (ROS)
[30,31] and nitric oxide (NO) [32,33] have been identi-
fied as playing roles. These findings may be of particular
importance for exposures at environmentally relevant low
doses where cells at risk are traversed by only single tracks
of radiation at any one time [34]. Bystander responses
may also be relevant to the therapeutic use of radiation
because a mechanistic understanding of the effects may
lead to approaches to enhance bystander responses in
tumours and also possibly to protect surrounding normal
tissues.
Although evidence shows that bystander responses can be
induced in many types of cells, it is not known whether
there is a radiation-induced bystander effect in breast can-
cer cells, where the radiosensitivity may be dependent on
the role of the cellular estrogen receptor (ER)[35]. Estro-
gens and anti-estrogens are important components of
breast cancer development and treatment. The experimen-
tal data are contradictory as to whether estrogens and anti-
estrogens alter the radiation response of breast cancer
cells. It has been reported that 17β-estradiol (E2) prevents
radiation-induced apoptosis of ER-positive MCF-7 breast
cancer cells, probably mediated through the plasma mem-
brane ER [36]. However, a number of studies have indi-
cated that estradiol treatment increases the
radiosensitivity of MCF-7 cells [37-39]. Conversely, treat-
ment with the anti-estrogen, tamoxifen reduces or does
not alter the radiosensitivity of MCF-7 cells [37,40],
although it has no effect on radiosensitivity of ER-negative
MDA-MB-231 breast cancer cells [41]. However, none of
these studies have considered the response of breast cells
and their modulation by estradiols and anti-estradiols
after low dose radiation exposure.
In the present work, we used a charged particle
microbeam to deliver exact numbers of helium ions
through the nuclei of restricted numbers of MCF-7 and
MDA-MB-231 breast cancer cells. We found that radia-
tion-induced bystander responses were generated in both
cell lines and that treatment with E2 and/or tamoxifen
influenced the bystander response through a ROS-medi-
ated pathway in only MCF-7 cells but not in MDA-MB-
231 cells.
Methods
Cell culture and treatments
ER-positive MCF-7 and ER-negative MDA-MB-231 breast
cancer cells (obtained from Cancer Research UK) were
cultured in DMEM medium supplemented with 10% (v/
v) foetal calf serum (FCS), 2 mM L-glutamine, 100 units/
ml penicillin, and 100 μg/ml of streptomycin. Cells were
grown in a humidified atmosphere with 5% CO2 in air at
37°C. One day prior to microbeam irradiation, plateau
phase cells were seeded at a low density in a φ5 mm cen-
tral area of the specially designed microbeam dish consist-
ing of a 3 μm thick Mylar film base [42]. The region
prepared for cell seeding had been pre-treated with 1.7 μg/
cm2 Cell-Tak adhesive (Collaborative Biomedical Prod-
ucts, Bedford, MA, USA). One hour after cell seeding, 2 ml
of medium was added into the microbeam dish. In some
experiments, cells were treated 24 h before and after
microbeam irradiation with 10 nM 17-β estradiol (E2), 50
nM tamoxifen (TAM), 150 U/ml of the antioxidants
superoxide dismutase (SOD) and catalase (CAT), or the
combination of E2 with either TAM or antioxidants (all
from Sigma, Poole, Dorset, UK). The concentration of E2
utilized for this study was within the range of physiologi-
cal concentrations which could saturate the ER. TAM with
a concentration of 5-fold excess was used to displace E2
from its receptor. These concentrations were also widely
applied in other studies [37,43].
Microbeam irradiation
The Gray Cancer Institute microbeam system was used for
this study and details of the experimental set-up have
been described elsewhere [42,44]. To enable individual
nuclei to be identified by the microbeam imaging system,
the fully-attached cells were stained with 0.2 μg/ml
Hoechst 33342 for 1 hr prior to irradiation. Excess stain
was removed by washing the cells with serum free
medium containing 10 mM HEPES before irradiation,
and cells were maintained in this medium during
microbeam irradiation. Typically, 1200 ± 50 (mean ± SE)
individual cells in total were scanned in the microbeam
dish just before irradiation. A fraction of cells, from 1% to
100% of the cells in the population, were individuallyBMC Cancer 2008, 8:184 http://www.biomedcentral.com/1471-2407/8/184
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irradiated through the center of the nucleus with a precise
number of helium-3 ions (3He2+) with an LET of 100 keV/
μm. Using these ions, 99% of cell nuclei could be pre-
cisely targeted with an accuracy of ± 2 μm. Immediately
after irradiation, the culture medium was replaced with 2
ml of complete medium with or without drugs and incu-
bation continued until treatment for micronucleus analy-
sis.
Micronucleus assay
The cytokinesis block technique was used to assay for
micronuclei (MN) in situ. 24 h after irradiation, the cul-
ture medium in the microbeam dishes was replaced with
medium containing 1 μg/ml cytochalasin-B. The cells
were incubated for a further 48 h then fixed with metha-
nol: acetic acid (9:1 (v/v)) for 20 min. After air-drying,
cells were stained with 10 μg/ml acridine orange plus 10
μg/ml Hoechst 33342 for 5 min. This Hoechst treatment
enhanced visualisation of both nucleus and micronu-
cleus. MN were scored in binucleated (BN) cells and clas-
sified according to the criteria of [45]. The MN yield, YMN,
was calculated as the ratio of the number of MN to the
number of scored BN cells.
ROS assay
To investigate the possible role of ROS in the E2-induced
effect, 2 × 105MCF-7 or MDA-MB-231 cells were treated
with 10 nM E2 or E2 plus 150 U/ml SOD and CAT for 24
h. Then, the intracellular ROS level in the cells was meas-
ured in situ by using 5',6'-chloromethyl-2',7'-dichlorodi-
hydro-fluorescein diacetate (CM-H2DCFDA, Molecular
Probes Inc.). Briefly, cells were treated with 3.5 μM CM-
H2DCFDA for 20 min at 37°C and then washed with FCS
free medium for 15 min. The fluorescence images of at
least 100 randomly selected cells per dish were captured
using a 3 CCD cooled colour camera (Photonic Science
Ltd, East Sussex, UK) attached to a fluorescence micro-
scope (Zeiss Axioskop). The exposure conditions were
standardised to allow quantitative comparisons of the rel-
ative fluorescence intensity of the cells between groups.
Statistical analysis
Statistical analysis was done on the means of the data
obtained from at least three independent experiments.
Two replicates were counted for each experimental point
in each experiment to determine the micronucleus yield.
All results are presented as means ± SE. Significance was
assessed using the Student's t-test at P < 0.05.
Results
Radiation induced bystander effect
When a fraction of either MCF-7 or MDA-MB-231 cells
within a population were individually targeted through
their nuclei with a precise number of helium particles,
MN were induced. The yields of MN in the targeted popu-
lations increased non-linearly with the fraction of irradi-
ated cells (Fig. 1). When 100% of cells were irradiated
with 1 or 5 3He2+ particles, the yield of radiation-induced
MN in the MDA-MB-231 cells was higher than that in the
MCF-7 cells, indicating that the MDA-MB-231 cells have a
higher radiosensitivity than MCF-7 cells. In contrast, it
was calculated from the data in Fig. 1 that, when 12 cells
(1% of the population) were individually targeted with 1
He2+ particle, although not every targeted cell leads to the
production of a MN, MN were still observed in an addi-
tional 33 MCF-7 cells or 29 MDA-MB-231 above back-
ground which provides clear evidence that MN are
produced in non-targeted bystander cells at a similar level
in both cell lines.
Radiation-induced MN formation in breast cancer cells Figure 1
Radiation-induced MN formation in breast cancer 
cells. Different fractions of cells within the populations of 
MCF-7 (A) and MDA-MB-231 (B) were individually irradi-
ated with 1 or 5 3He2+ particles, respectively.BMC Cancer 2008, 8:184 http://www.biomedcentral.com/1471-2407/8/184
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If no bystander effect occurred in the population where
100% of cells were targeted individually, the yields of MN
when only a fraction of the cells were irradiated can be
mathematically predicted. This uses the MN yield when
100% of cells were irradiated by the method described
previously [32] and the yields are listed in Table 1. In
comparison to the data in Fig. 1, the predicted MN yields
are smaller than the measured values for both the MCF-7
and MDA-MB-231 cell lines. The difference in yield of MN
between the measured value and the predicted value is
defined as the yield of bystander MN (see Table 1). In gen-
eral, the bystander MN yield increased with the fraction of
irradiated cells and with the radiation dose (number of
particles delivered to the targeted cells). In addition,
although the bystander MN yield in MBA-MD-231 cells
was higher than that of MCF-7 cells, the bystander MN as
a percentage of the total MN in the MDA-MB-231 popula-
tion was less than that of MCF-7 cells. For example, when
1 to 20% of cells in a population are irradiated with 1 or
5 3He2+ particles, the bystander MN as a percentage of the
total MN ranges from 5.8% to 18.9% for the MDA-MB-
231 cells, and from 27.1% to 40.1% for the MCF-7 cells.
Therefore, MCF-7 cells are more effective in generating a
bystander response than MDA-MB-231 cells, which is in
contrast to the differences in radiosensitivity between the
two cell lines.
Influence of E2 and TAM on the bystander response
E2 is an important factor involved in breast cancer devel-
opment. To investigate whether E2 can influence the radi-
ation-induced bystander effect, we treated cells with E2 for
24 h before irradiation and afterwards until assayed for
MN. Results are illustrated in Fig. 2 where a fraction of
either MCF-7 or MDA-MB-231 cells were individually irra-
diated with 5 3He2+ particles. The E2 treatment itself sig-
nificantly increased the MN background in MCF-7 cells (P
< 0.05) but not in MDA-MB-231 cells, which is in agree-
ment with a previous report that E2 increases the forma-
tion of MN in ER-positive MCF-7 cells [46]. When 100%
of the cells were irradiated, E2 also increased the produc-
tion of MN in MCF-7 cells and this increase is larger than
the E2-enhanced MN background (Fig. 2A). However, E2
had no influence on MDA-MB-231 cells (Fig. 2B). There-
fore, E2 increases the radiosensitivity of MCF-7 cells but
not MDA-MB-231 cells.
Interestingly, the MN yield was also increased by E2 treat-
ment when 1% or 10% of cells in the MCF-7 population
were irradiated. According to the MN yield when 100% of
cells were irradiated in the presence of E2, the predicted
yield of MN, assuming no bystander effect occurred in the
fraction-irradiated population, and the yield of bystander
MN in the E2-treated MCF-7 cells were calculated and are
listed in Table 2.
Comparing the data in table 2 with those in table 1, it is
seen that treatment of MCF-7 cells with E2 increased the
yield of bystander MN when 1% or 10% of the cells were
individually irradiated with 1 or 5 3He2+ particles. For
example, when 1% of cells were irradiated with 1 3He2+
particle, E2 increased the bystander MN yield from 0.0262
to 0.0347. This E2-enhanced bystander response could
result from the E2-enhanced radiosensitivity of MCF-7
cells.
Figure 2 also illustrates that when the cells were treated
with TAM to compete for ER with E2, both radiosensitivity
and the radiation-induced bystander effect on MCF-7 cells
were diminished to the levels in the absence of E2 treat-
ment. In addition, treatment of cells with TAM plus E2 did
not show any influence on radiation damage to MDA-MB-
231 cells. Treatment with TAM alone had no influence on
the radiosensitivity of either cell line (data not shown).
ROS contributes to the E2-enhanced radiation effect in 
MCF-7 cells
To investigate the signaling factors involved in the E2-
enhanced cellular damage in MCF-7 cells, we measured
the levels of intracellular ROS in cells with or without E2
treatment. Fig. 3 illustrates that, when MCF-7 cells were
treated with 10 nM E2 for 24 h, the levels of ROS
increased 1.17 fold relative to controls. When SOD and
CAT were present during E2 treatment, the level of ROS in
MCF-7 cells was decreased to 93% of the control. In the
Table 1: The predicted yield of MN and the measured yield of bystander MN.
MCF-7 cells MDA-MB-231 cells
Predicted YMN Bystander YMN Predicted YMN Bystander YMN
Fraction of irradiated cells 1 3He2+ 5 3He2+ 1 3He2+ 5 3He2+ 1 3He2+ 5 3He2+ 1 3He2+ 5 3He2+
1% 0.071 0.071 0.026 (27.1%) 0.037 (34.3%) 0.308 0.309 0.024 (7.2%) 0.019 (5.8%)
10% 0.084 0.091 0.039 (31.9%) 0.054 (37.5%) 0.330 0.343 0.054 (14.0%) 0.080 (18.9%)
20% 0.098 0.11 0.044 (31.0%) 0.077 (40.1%) 0.354 0.380 0.069 (16.4%) 0.080 (17.4%)
A fraction of cells within the MCF-7 and MDA-MB-231 populations were individually irradiated with a precise number of 3He2+ particles. Data in 
parentheses are the bystander MN as a percentage of total MN.BMC Cancer 2008, 8:184 http://www.biomedcentral.com/1471-2407/8/184
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ER-negative MDA-MB-231 cells, E2 treatment had no
influence on the levels of ROS although treatment with
antioxidants decreased the intracellular levels of ROS (not
significant).
To investigate whether the E2-induced ROS contributes to
the radiation-induced bystander response, we measured
the yield of MN in the fraction-irradiated MCF-7 popula-
tion treated with SOD and CAT antioxidants in the pres-
ence of E2. Results are shown in Fig. 4 where 10% and
100% of MCF-7 cells were individually irradiated with 1
3He2+ particle. The antioxidant treatment eliminated the
E2-enhanced MN background, which corresponds to the
result in Fig. 3 and hence confirms that ROS are the source
of E2-induced MN in MCF-7 cells. Importantly, when
100% of MCF-7 cells were irradiated, the antioxidant
treatment not only diminished E2-enhanced MN forma-
tion but reduced the MN to a very low level, which indi-
cates that ROS contribute to the DNA damage induced by
direct radiation. From the measured MN yields when
100% of the cells were irradiated with antioxidant treat-
ment, we calculated the predicted MN yield assuming no
bystander effect occurred when 10% of cells were irradi-
ated and found that this matched the actual MN yield
(Fig. 4). Accordingly, ROS not only contribute to the
direct radiation-induced cellular damage but are also
involved in the E2-enhanced bystander response of MN
induction in MCF-7 cells.
Discussion
This study finds that, when a fraction of cells are precisely
irradiated with a counted number of 3He2+ particles, the
bystander response, measured as an increased yield of
MN, can be produced in both non-irradiated MCF-7 and
MDA-MB-231 cells, independent of ER status. Radiation-
induced signalling factors could contribute to these
bystander responses. For example, it has been reported
that the conditioned medium from irradiated MCF-7 or
MDA-MB-231 cells contained twofold more TGF-β1 than
that from nonirradiated cells [47]. Also significant evi-
dence for the role of paracrine signalling in response to
radiation exposure has been reported (See [48]for a
review). Our previous studies have shown that TGF-β1 is
an important t bystander signaling factor which can fur-
ther raise the level of intracellular ROS and NO and then
cause DNA damage [49,50].
Interestingly, the contribution of the bystander response
to cellular damage in ER-positive MCF-7 cells was higher
than that in ER-negative MDA-MB-231 cells. Moreover,
treatment of cells with E2 increases the radiation-induced
bystander damage in the ER-positive MCF-7 cells but not
in the ER-negative MDA-MB-231 cells, and this E2-
enhanced bystander response in MCF-7 cells can be
reversed by tamoxifen, an anti-estrogen reagent.
The effects of E2 on breast cancer cells are complicated
and sometimes inconsistent. It has been reported that E2
acts as both a growth factor and a survival factor for breast
cancer cells and prevents cell death from apoptosis [36].
However, E2 is a carcinogen and can induce multiple
forms of DNA damage such as single strand breaks, chro-
mosome aberrations, and gene mutations [51]. We find
here that the effect of E2 on DNA damage is dependent on
the ER status of the cells. E2 can induce MN in ER-positive
MCF-7 cells but not in ER-negative MDA-MB-231 cells,
which is in agreement with other studies [46,52]. Fisher et
al. suggested that the E2-induced formation of MN was
not due to the chromosome damaging activity of estradiol
Influence of E2 and TAM on radiation-induced MN formation Figure 2
Influence of E2 and TAM on radiation-induced MN 
formation. A fraction of MCF-7 (A) or MDA-MB-231 (B) 
cells were individually irradiated with 5 3He2+ particles with-
out or with pre-treatment with E2 or E2+TAM (*, P < 0.05 
compared to the MN yield without E2 treatment).BMC Cancer 2008, 8:184 http://www.biomedcentral.com/1471-2407/8/184
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but to stimulation of MCF-7 proliferation. For our experi-
ment, the cells were seeded on dishes pre-treated with
Cell-Tak so that the cell plating efficiency was ~100%;
shortly after irradiation, the cell growth was blocked by
cytochalasin-B. Under these conditions, we did not find
that the cell proliferation was increased by E2. Thus, E2-
induced MN in MCF-7 cells reported here could not result
from increased cell proliferation but is generated from the
cytotoxic effect of E2.
Direct evidence in the present study shows that E2-
induced responses of ROS and MN induction are ER-
dependent. Also, the ROS produced contribute to E2-
induced DNA damage in MCF-7 cells since this damage
was reduced by antioxidants. It has been reported that sev-
eral types of free radical-mediated DNA damage can be
induced by estrogens and their metabolites. For instance,
8-hydroxyguanine, formed by hydroxyl radical reaction
with guanine bases, is increased over control values in
DNA of cells incubated with estradiol [53]. In fact, the
genotoxic activity of E2 is thought to be tightly linked to
an oxidative element probably involving an ER-mediated
mechanism. At physiological concentrations of E2, an ER-
mediated pathway is more capable of inducing increases
in ROS through the regulation of antioxidant genes [43].
E2 can be preferentially oxidised by cytochrome P-450 to
produce 2-hydroxyestradiol that reacts with DNA and can
be further oxidized to quinone acocmpanied by genera-
tion of ROS [54].
Moreover, we find that the E2-induced ROS contribute to
the E2-enhanced radiosensitivity and bystander response
of MCF-7 cells (Fig. 4). However, ROS may not be the only
signalling factor involved in the bystander response
because they can be produced in both irradiated and non-
irradiated cells after E2-treatment. We have recently found
that nitric oxide (NO) can be produced in irradiated MCF-
7 cells. Even when only 1% of cells are targeted, the NO
level in the whole cell population can be increased by
19% relative to controls (data not shown). One possibil-
ity is that ROS increases not only the E2-enhanced radio-
sensitivity of MCF-7 cells but also the cellular sensitivity to
other toxic factors including NO and its downstream
products induced by radiation so that the bystander
response of cellular damage can be increased by the E2-
treatment. As E2 is an essential factor for the development
and growth of breast cancer cells, our finding that E2
increases the radiation-induced bystander effect may have
relevance for the future development of radiation-
dependent therapies for breast cancer.
Bystander responses have also been observed in breast
tumour cells after various chemical treatments. For exam-
ple, using a co-culture approach, Chhipa and Bhat
reported increased bystander cell killing in MCF-7 cells
co-culutred with MDA-MB-231 cells which had been pre-
treated with 5-fluorouracil (5-FU) and this was mediated
by the Fas/FasL system [55]. In another study pre-treat-
ment of breast cells with paclitaxel, leads to increased ROS
levels and this could produce increased cell killing in non
paclitaxel treated bystander cells [56].
Table 2: The predicted yield of MN and the measured yield of bystander MN in MCF-7 cells.
Fraction of irradiated cells Predicted YMN Bystander YMN
1 3He2+ 5 3He2+ 1 3He2+ 5 3He2+
1% 0.010 0.010 0.035 (25.8%) 0.057 (36.2%)
10% 0.114 0.124 0.067 (37.1%) 0.072 (36.7%)
A fraction of cells within the population, which had been treated with E2 for 24 h, were individually irradiated with a precise number of 3He2+ 
particles. Data in parentheses are the bystander MN as a percentage of total MN.
Relative ROS levels Figure 3
Relative ROS levels. MCF-7 cells and MDA-MB-231 cells 
were treated with E2 or the mixture of E2 and SOD plus 
CAT (*, P < 0.01 compared to the control without E2 treat-
ment).BMC Cancer 2008, 8:184 http://www.biomedcentral.com/1471-2407/8/184
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Conclusion
We report here evidence for radiation-induced bystander
responses in breast tumour cells. In MCF-7 cells, the
bystander response could be enhanced by treatment with
E2 and quenched by the addition of TAM in an ROS
dependent manner, neither of which modulated the
bystander response in MDA-MD-231 cells. The observa-
tion of bystander responses in breast tumour cells may
offer new potential targets for radiation-based therapies in
the future.
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